Blog
RSS FeedPosted by Michael Wonder on 16 Jun 2016
Agenda for the 22 June 2016 TC meeting
16 June 2016 - The Transparency Commission will consider the reimbursement of glatiramer acetate (Copaxone), ruxolitinib phosphate (Jakavi), clobazam (Likozam) and ...